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ABSTRACT 
Objective: The aim of this study was to develop a bioadhesive gel of gatifloxacin for the treatment of periodontal diseases. 
Methods: Periodontal gels of gatifloxacin were prepared using different hydrophilic polymers such as carbopol 940 (CP 940), carboxymethyl 
cellulose (CMC) and hydroxypropylmethyl cellulose (HPMC) in varied concentrations, either alone or as a combination. The prepared gels were 
evaluated for their physical appearance, pH, drug content, viscosity, bioadhesiveness and in vitro drug release profile. The influence of the type and 
the concentration of polymer on the drug release as well as on viscosity and mucoadhesiveness of prepared gels were investigated. 
Results: The prepared gels showed acceptable physical properties concerning color, homogeneity, consistency, spreadability, and pH value. Using 
different polymer types at different concentrations, as well as different polymer combinations, play a significant role in the variation of overall 
characteristics of formulations. Increasing the concentration of polymer increased the viscosity as well as mucoadhesion, and reduced drug release 
rate. Formulation F 11 (1 % CP 940 and 5 % CMC) was selected as the formula of choice based on the data of various evaluation parameters such as 
pH, drug content, viscosity, spreadability and bioadhesion as well as its ability to show a prolonged drug release pattern.  
Conclusion: The obtained results show that a bioadhesive periodontal gel of gatifloxacin can be prepared using hydrophilic polymers, and by using 
a combination of polymers the viscosity, mucoadhesiveness, spreadability and release behavior can be optimized. 
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Periodontal disease is an infectious condition caused by bacterial 
accumulation that involves gingiva but can also spread to deeper 
supporting tissues of the teeth, leading to inflammation and 
degeneration of the gingiva and tooth loosening and eventually teeth 
loss when left untreated [1]. Several approaches to treat 
periodontitis range from mechanical debridement of tooth surfaces 
to systemic or local administration of antimicrobial agents [2, 3]. 
Because of significant side effects associated with the systemic 
administration of antibiotics, this approach of treatment should only 
be used in patients who respond poorly to mechanical treatment [4]. 
Local antimicrobial delivery system in periodontal pockets overcome 
limitations caused by systemic drug administration and has the benefit 
of maintaining adequate concentration of drugs at the target site. It have 
been carried out using a variety of approaches including oral rinses, sub-
gingival irrigation and antimicrobial agents controlled release delivery 
systems such as fibers, films, chips, gels, ointments, and micro-particles 
which have been seen to be effective methods to administer 
antimicrobial agents in periodontal therapy [5, 6]. 
Gatifloxacin (GT) is a fourth generation fluoroquinolone, with a 
broad antibacterial spectrum, including a number of aerobic, 
anaerobic, gram positive bacteria, is was shown to be highly active 
against penicillin sensitive and resistant Streptococcus pneumoniae, 
Staphylococcus aureus, Streptococcus pyogenes and Streptococcus 
agalactiae and a number of gram-negative microorganisms [7]. The 
aim of the present study was to formulate bioadhesive periodontal gels 
of gatifloxacin with appropriate viscosity, spread ability, and release 
behavior so as to provide localized and prolonged drug release for better 
management of local periodontal infections. 
MATERIALS AND METHODS 
Materials 
Gatifloxacin (gift from Kanawati pharmaceutical company, Syria), 
carbopol 940 (CP940), hydroxyl propyl methyl cellulose (HPMC) 
(Himedia, India), carboxy methyl cellulose (CMC) (supplied by 
Samarra Drug industries, Iraq), agar (Himedia, India), 
triethanolamine (TEA) (Hopkins and Williams Ltd., England), citric 
acid, disodium hydrogen phosphate, mannitol, methylparaben (MP) 
and propyl paraben (PP) (Gainland Chemical Co. Ltd., UK). All 
chemicals used were of analytical grade. 
Methods 
Preparation of gatifloxacin periodontal gels 
Gatifloxacin (GT) periodontal gels were prepared using Varshosaz et 
al. method [8]. To prepare the gels, weighed amounts of the polymers 
(CP 940, CMC, or HPMC) was dissolved in 75 ml of McIlvaine buffer 
(pH 6.6) using a magnetic stirring bar. Gatifloxacin (0.5 % w/v) was 
dissolved in small volume of 0.1 N HCl solution, then the drug solution 
was added to the polymeric solution with stirring. Mannitol, and 
preservatives (methyl and propyl paraben) were added with 
continuous stirring to the formulation and volume was then brought 
up to 100 ml using McIlvaine buffer (pH 6.6).  
The pH of gels containing CP 940 was adjusted to pH 6.8 using 
triethanolamine. The prepared gel formulations were stored in 
suitable wide mouth plastic jars with a screw capped lids at room 
temperature until required. Table 1 shows the composition of all the 
formulations. 
Evaluation of gatifloxacin periodontal gels 
Physical appearance of gel formulations 
All prepared formulations were visually inspected for their color, 
consistency, homogeneity, presence of aggregates, grittiness and 
phase separation after the gels have been set in the container [9]. 
pH determination 
The measurement of formulations pH was done using a digital 
pH meter (CG 820, Schott Geräte GmbH, Hofheim, Germany) by 
dipping the electrode completely into the gel so as to cover the 
electrode. Obtained values were the average of three readings 
[10]. 
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Estimation of drug content 
Accurately weighed amount of formula (1 g) equivalent to 5 mg of 
gatifloxacin was taken in a 100 ml of McIlvaine buffer (pH 6.6) in 
volumetric flask. The volumetric flask was sonicated to get complete 
solubility of the drug, and then kept overnight for complete 
dissolution. After filtration through 0.45μm membrane filter, 1 ml of 
the solution was diluted to 10 ml with McIlvaine buffer (pH 6.6) and 
drug absorbance of sample solution was determined against 
McIlvaine buffer (pH 6.6) as a blank and at λ max 286 nm using 
Biotech 9200 UV Vis spectrophotometer.  
The drug content was calculated from the linear regression equation 
obtained from the calibration data [11]. 
 
Table 1: Compositions of gatifloxacin periodontal gel formulations 
Ingredients (% w/v) 
Code Drug CP 940 CMC HPMC Mannitol MP PP McIlvaine buffer (pH 6.6, up to)* 
F1 0.5 0.75 ------- ------- 1 0.18 0.02 100 ml 
F 2 0.5 1.0 ------- ------- 1 0.18 0.02 100 ml 
 F 3 0.5 1.5 ------- ------- 1 0.18 0.02 100 ml 
 F 4 0.5 ------- 3 ------- 1 0.18 0.02 100 ml 
F 5 0.5 ------- 5 ------- 1 0.18 0.02 100 ml 
F 6 0.5 ------- 7 ------- 1 0.18 0.02 100 ml 
F 7 0.5 ------- ------- 5 1 0.18 0.02 100 ml 
F 8 0.5 ------- ------- 10 1 0.18 0.02 100 ml 
F 9 0.5 ------- ------- 15 1 0.18 0.02 100 ml 
F 10 0.5 1.0 3 ------- 1 0.18 0.02 100 ml 
F 11 0.5 1.0 5 ------- 1 0.18 0.02 100 ml 
F 12 0.5 1.0 ------- 5 1 0.18 0.02 100 ml 
F 13 0.5 1.0 ------- 10 1 0.18 0.02 100 ml 
F 14 0.5 ------- 3 5 1 0.18 0.02 100 ml 
F 15 0.5 ------- 3 10 1 0.18 0.02 100 ml 
*Carbopol containing formulations were adjusted to pH 6.8, CP 940 = carbopol 940, CMC = carboxymethyl cellulose, HPMC =hydroxypropyl 
methylcellulose, MP = methyl paraben, PP = propyl paraben 
 
Viscosity study 
Viscosity of formulations was studied using Myr VR 3000 digital 
viscometer. Viscosity of the samples was measured at 25○
Spreadability 
 C 
using 100 ml aliquots. Measurements were made at 100 rpm 
using a suitable spindle number depending on the sample 
viscosity. The average of three readings was used to calculate 
the viscosity and obtained values were recorded as milliPascals 
per second (mPa. s) [12]. 
The spreadability of formulations was determined 48 h after 
preparation by parallel plate method [13]. A sample (1g) of the 
formulation was transferred to the center of glass plate (20 x 20 cm) 
placed over a paper on which concentrically divided squares of 1 mm 
sides were drawn, and spread over an area of 1 cm2
Bioadhesion study 
. Another glass 
plate having a mass of 100 g was placed gently on the formulation, and 
2 kg weight was placed at the center of the plate with care to avoid 
sliding of the glass plate. The spread diameter in cm was measured 
after 3 min where no more spreading was expected. Results obtained 
are the average of three determinations [14]. 
Adhesiveness of formulations was measured by the plate agar 
method. An agar plate (containing 2% w/v agar) of 5 cm in diameter 
was prepared; 1 g of the formulation was placed on the center of the 
agar plate, making a circle of 1 cm in diameter. The plate was slanted 
at 30 ° for 1 hour and the longest distance moved by the sample was 
measured at room temperature [15]. 
In vitro drug release study  
In vitro drug release study was carried out using RC-6 dissolution 
tester. One gram of the formulation was weighed on an analytical 
balance and spread evenly on the surface of a watch glass, then was 
gently lowered through 500 ml of the dissolution medium 
(McIlvaine buffer; pH 6.6). The paddle of the dissolution apparatus 
was centrally positioned 2.5 cm above the watch glass. The release 
study was carried out at 37±0.5 ○
Drug release data analysis 
C and the paddles were rotated at a 
stirring rate of 50 rpm. Aliquots of 5 ml were withdrawn at specified 
time intervals and immediately replaced by the same volume of 
fresh dissolution medium. The samples were assayed 
spectrophotometrically at λ max 286 nm and the concentration of 
the drug was determined from a previously constructed calibration 
curve. Experiments were carried out in triplicates; the results were 
averaged [16].  
To describe the kinetics of gatifloxacin release, data from the in vitro 
drug release study were fitted to different mathematical models 
such as zero-order, first order, Higuchi’s model and Korsmeyer–
Peppas model to evaluate the release mechanism of drug. The 
criterion for selecting the most appropriate model was based on a 
goodness-of-fittest [17]. 
Statistical analysis 
The obtained data were analyzed statistically by the one-way 
analysis of variance (ANOVA) test at 95 % confidence level using 
Microsoft Excel 2010 software. The values were expressed in mean 
values±SD (Standard Deviation) of three replicates. Probability 
values of 0.05 or less (p<0.05) was considered statistically 
significant [18]. 
RESULTS AND DISCUSSION 
Physical appearance of gel formulations 
Prepared formulations were off-white to pale yellow(due to the 
color of the drug) viscous preparations, showing no phase 
separation, with smooth, aggregate free homogeneous texture with 
variable consistency ranging from liquid to thick gel preparations. 
Results are shown in table 2. 
pH determination 
The pH values of the prepared gels was found to be between 6.6 to 
6.8 (table 2) which was well within the normal pH range of buccal 
cavity of 6 to 7;this is considered acceptable to avoid the risk of 
irritation upon application to oral mucosa. 
Estimation of drug content 
The data of drug content from all the prepared formulations show 
that the values range between 95.88 % and 100.58 %, representing 
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homogenous drug distribution throughout the gel. Results of drug 
content are shown in table 2.  
Viscosity study 
An important requirement for a gel for periodontal use is its 
viscosity.  
It should be in a range which will allow ease of application and 
permit the formulation to stay at site of application. There is no 
established criteria for the viscosity of periodontal gel, but a high viscose 
bio adhesive gel tend to retain at the site of application withstanding 
saliva washout and the mechanical stress while lower viscosity gels are 
easily administered to periodontal tissue by using a syringe. 
 
Table 2: Physical properties of gatifloxacin periodontal gels 
Formulation code Appearance pH Drug content (%)  
 F 1 Clear, pale yellow liquid Adjusted to 6.8 95.88±0.1 
 F 2 Clear, yellowish white viscous liquid Adjusted to 6.8 98.70±0.2 
 F 3 Transparent, pale yellowish white gel Adjusted to 6.8 99.88±0.33 
 F 4 Translucent yellow liquid 6.6±0.03 100.58±0.4 
 F 5 Translucent yellow gel 6.6±0.01 97.17±0.6 
 F 6 Translucent yellow gel 6.6±0.02 97.05±0.4 
 F 7 Yellow, transparent liquid 6.6±0.02 97.64±0.3 
 F 8 Yellow, transparent viscous liquid 6.6±0.01 96.88±0.6 
 F 9 Yellow, transparent viscous thick liquid 6.6±0.03 100.52±0.1 
 F 10 Translucent, pale yellow gel Adjusted to 6.8 98.82±0.5 
F 11 Translucent, pale yellow gel Adjusted to 6.8 100.54±0.3 
F 12 Translucent, pale yellow gel Adjusted to 6.8 97.29±0.2 
F 13 Translucent, pale yellow gel Adjusted to 6.8 96.47±0.1 
F 14 Translucent, yellow gel 6.67±0.02 99.41±0.3 
F 15 Translucent, yellow gel 6.68±0.01 98.4±0.4 
(Values represent mean±SD, n=3) 
 
The obtained viscosity values of gatifloxacin gel formulations were 
in the range of 170–35850 mPa. s, as shown in table 3. For each of 
the three polymer studied (CP 940, CMC and HPMC), viscosity of the 
formulations was found to be affected by the type of polymer used 
although these polymers were not used at the same concentration 
ranges. Viscosity of gel formulations with carboxymethyl cellulose 
was high as compared to that of HPMC and carbopol. Furthermore, 
the viscosity of the formulations was found to be influenced by the 
concentration of polymers used; a significant increase (p<0.05) in 
viscosity was observed with increasing polymer concentrations. This 
may be due to higher degree of cross linking at higher 
concentrations of polymers. This is in accordance with results 
reported by Aslani et al. on their study on herbal gels as periodontal 
drug delivery system [19].  
Formulations containing combinations of polymers (F10-F15), are 
more viscous then those containing only one polymer. Formulation 
F15 (3 % CMC and 10 % HPMC) exhibits highest viscosity (35850 
mPa. s) whereas formulation F12 (1 % CP 940 and 5 % HPMC) 
exhibits lowest viscosity (2750 mPa. s). These results are in 
accordance with the finding of Biswas et al.[20] and Yellanki et 
al.[21]. 
Spreadability 
The spreadability values for gatifloxacin periodontal gels ranged 
from (7.5-12.5) cm as shown in table 3, indicating ease of 
spreadability using small amount of shear.  
Spreadability was not much influenced by the type of polymer used. 
However, data revealed that spreadability decreases with increasing 
polymer concentration as expressed by the lower diameter of the 
spread circle. Similar observations was shown by Helal et al. when 
formulating fluconazole topical gel using different polymers with 
different concentrations [22]. 
Formulations prepared using a combination of polymers (F10-F15) 
had lower spreadability values compared to formulations composed 
of only one polymer. 
 
Table 3: Viscosity, spreadability and mucoadhesion test of gatifloxacin periodontal gel formulations 
Formulation code Viscosity (mPa. s) at 100 
rpm 
Spindle number Spreadability diameter 
(cm) 
Mucoadhesion test 
(distance moved, cm) 
F 1 330±1.43 R5 12.5±0.3 >4 
F 2 650±2.4 R5 11.5±0.4 1.5±0.2 
F 3 3610±1.5 R5 11±0.2 0.1±0.1 
F 4 1275±1.35 R5 12±0.1 0.9±0.3 
F 5 6450±2.45 R7 11±0.5 0.5±0.2 
F 6 25500±2.02 R7 8±0.3 0.3±0.1 
F 7 170±1.14 R3 15±0.4 >4  
F 8 2600±1.36 R7 12±0.2 >4 
F 9 21150±1.79 R7 9.5±0.4 1.5±0.1 
F 10 12100±1.66 R7 10±0.5 0.4±0.2 
F 11 28050±2.55 R7 7.8±0.2 0.3±0.1 
F 12 2750±1.08 R7 12±0.1 1±0.2 
F 13 11000±2.4 R7 10.5±0.2 0.5±0.1 
F 14 3850±1.8 R7 11±0.5 0.9±0.2 
F 15 35850±2.6 R7 7.5±0.1 0.2±0.1 
(Values represent mean±SD, n=3) 
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Bioadhesion study 
Adhesive property is an important parameter in the design of 
periodontal gel, since a better clinical efficacy is obtained upon a 
good gel contact and retention at the mucosal surface. In the current 
study, the movement distance was used to determine the adhesive 
properties of the formulations on the agar plate. The shorter the 
movement distance, the better adhesion was between the polymer 
and the agar plate. 
The effect of polymer type and concentration besides the effect of 
using a combination of polymers on the movement distance 
observed by different gel formulations on the agar plate are 
summarized in table 3. 
Regarding the type and concentration of polymer, it was observed that 
the type of polymer will greatly affect bioadhesion and the movement 
distance of the formulation appeared to be inversely related to the 
polymer concentration; increasing the concentration of each polymer 
will provide better adhesion and hence longer residence time.  
Ranking the bioadhesiveness in a descending order for each polymer 
was as follows: CMC (F6>F5>F4), CP 940 (F3>F2>F1) and HPMC 
(F9>F8>F7).  
It is evident that movement distance of periodontal gels on the agar 
plate was influenced by their viscosities; higher viscosity gels tend 
to have longer residence time on agar and produce lower movement 
distance (table 3). This is in accordance with results reported by 
Songkro et al. on their study on nicotinamide oral gels [23]. 
Both CMC, a homo-polymer, and CP 940, a cross-linked polymer, 
form numerous hydrogen bonds due to their high molecular weights 
and their anionic nature (at buccal pH), which causes extensive 
swelling, changing their conformation and allowing for more agar-
polymer interpenetration. However, the absence of cross-linking in 
CMC as compared to CP allows more freedom for diffusion and 
entanglement with agar making formulation based on CMC to have 
the best bioadhesion. HPMC based periodontal gels have the lowest 
bio-adhesive effect, due to the non-ionic nature and lower molecular 
weight of HPMC [24]. 
Formulations composed of a combination of polymers (F10-F15) 
showed a lower distance of movement on agar plate compared to 
their counterparts composed of single polymers; this means that 
there is a synergistic effect between polymeric combinations to 
increase bio adhesiveness: a favorable effect that causes retention 
of the formula to the site of application for the desired period of 
drug release. These results are in accordance with the finding of 
Roy et al. [25]. 
In vitro drug release study  
The release profile of gatifloxacin in McIlvaine buffer (pH 6.6) from 
different formulations was studied. For all formulations prepared, 
most of the gel dissolved within 6 h. The release profile was biphasic 
in nature, with an initial phase of high release (burst effect) followed 
by a second phase of moderate release. Burst release can be 
attributed to the drug which is present freely in the gel matrix. This 
was most evident for gels based on carbopol or HPMC. Considering 
the initial microbial load in the periodontal pocket, it is desirable to 
have a burst release of antimicrobial agents [26]. 
Graphical representation of release profile for periodontal gels 
prepared using a single polymer at different concentrations (F1-F9) 
is shown in fig.1. Drug release was significantly dependent on 
polymer type, and release profiles can be ranked in the following 
order: CP 940 (F1-F3)>HPMC (F7-F9)>CMC (F4-F6) where the 
amounts of the drug released after 120 min were 95-100% (F1-F3), 
75-85 % (F7-F9) and 42-52 % (F4-F6), respectively. Formulation F1, 
which contained 0.75% CP 940, seemed to give the highest release 
rate of gatifloxacin among the formulations tested. 
Regarding the polymer concentration, the graph demonstrates that 
increasing individual polymer concentration will decrease drug 
release rate. This may be due to the fact that increasing polymer 
concentration will increase viscosity of gels as well increasing polymer 
cross linking; this will reduce migration of drug molecules and 
decreased drug release. These results are similar to observations 
reported by Parhi et al. [27], Kalia et al. [28] and Mekkawy et al. [29]. 
In an attempt to enhance the drug release profile observed with gels 
based on CP or HPMC alone, gels were formulated using combination 
of polymers; namely gels composed of CMC/CP (F10-F11), HPMC/CP 
(F12-F13) and CMC/HPMC (F14-F15). Release profiles of these 
formulations were studied and are shown in fig. 2 with comparison to 
the release profile obtained when using single polymer formulas. 
Gels containing 1 % carbopol alone (F2) produce significantly 
(p<0.05) higher drug release compared to gels containing 
combination of two polymers CMC/CP (F10, F11) and HPMC/CP 
(F12, F13). This could be due to the fact that carbopol undergo 
ionization at pH of the dissolution media and negative charges are 
developed along the backbone of the polymer leading to repulsion. 
Such an effect increases water uptake and causes the drug to diffuse 
from the formulation at a faster rate [30]. 
 
 
Fig. 1: Comparative drug release profiles of gatifloxacin periodontal gel formulations containing a single polymer (F1-F9) 
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For formulations produced by combining CMC with HPMC (F14 and 
F15), a significantly (p<0.05) higher drug release rate was observed 
when compared to formula containing 3 % CMC alone (F4) and a 
non-significant (p>0.05) higher drug release rate as compared to 
formulations containing HPMC alone (F7 and F8).  
The increase in drug release rate was because of the hydrophilicity 
of this polymeric gel combination, and since F14 and F15 contain 
higher concentrations of HPMC than CMC, the release profiles 
obtained by them were closer to that seen with formulations 
containing 5 and 10 % HPMC (F7 and F8, respectively) than to 
formula F4 containing 3 % CMC alone.  
It appears that periodontal gels of gatifloxacin prepared from binary 
polymeric mixtures exhibit different rates of drug release according to 
the nature of the gel-forming polymer as well as its concentration. As 
depicted in fig. 2, combination gels rich in HPMC (F12-F15) produced 
fast and poorly reproducible drug release profiles while combination 
gels based on CMC/CP (F10, F11) were able to produce a slower, more 
prolonged release profile of gatifloxacin extending for more than 6 h. 
  
 
Fig. 2: Comparative drug release profiles of gatifloxacin periodontal gel formulations containing combination polymers (F10-F15) 
compared to corresponding formulations containing a single polymer 
 
Drug release data analysis 
In vitro drug release data were fitted to various release models, 
namely zero order, first order, Higuchi and Korsmeyer-Peppas. Results 
showed that drug release followed Higuchi model, this means that 
release of gatifloxacin from these formula was due to diffusion. 
The release exponent value (n) for most of the formulations was less 
than 0.5, suggesting that the drug release followed Fickian diffusion 
mechanism, except for F5 and F10 which showed release exponent 
value between 0.5 and 1.0 indicating non-Fickian (anomalous) 
diffusion mechanism, the polymer relaxation rate being 
approximately equal to drug diffusion rate though polymer network; 
while F6 and F11 follow zero order drug release mechanism. 
However, zero order models are not suited to analyze swellable 
matrix systems, and were therefore rejected.  
Among the Korsmeyer-Peppas equation and Higuchi models, by 
considering the higher correlation coefficient value (R2
  
), the release 
data seem to fit the Higuchi model better. The data is shown in table 4. 
Table 4: Drug release model fitting of different gatifloxacin periodontal gel formulations to various kinetic models and their regression 
coefficients 










exponent (n) ) 
Kinetic 
constant (k) 
F1 0.7557 0.7394 0.8399 0.8973 0.2674 3.371 
F2 0.9049 0.8943 0.9576 0.8943 0.0006 4.5095 
F3 0.7474 0.7207 0.8401 0.9264 0.0554 4.2929 
F4 0.8072 0.8175 0.7945 0.7909 0.0949 3.4965 
F5 0.5277 0.3349 0.6616 0.6325 0.6125 0.7187 
F6 0.7797 0.5871 0.8913 0.863 0.9318 1.1581 
F7 0.5798 0.5913 0.4885 0.4006 0.0245 4.333 
F8 0.9313 0.9287 0.9429 0.919 0.0248 4.2286 
F9 0.6677 0.6283 0.7851 0.8817 0.0747 3.9524 
F10 0.6182 0.439 0.7584 0.7578 0.7249 0.1251 
F11 0.7344 0.3631 0.8626 0.667 1.2363 2.6033 
F12 0.6995 0.6581 0.7995 0.8754 0.0701 4.2018 
F13 0.7067 0.6517 0.8203 0.898 0.1527 3.7418 
F14 0.6435 0.5828 0.7639 0.8586 0.1724 3.6572 
F15 0.76 0.683 0.8739 0.9287 0.2018 3.4604 
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CONCLUSION 
This study focused on the development of gatifloxacin containing gels for 
periodontal administration. The study has shown that by using different 
types of polymers or polymeric combinations and at different 
concentrations the rheological, bioadhesion and drug-release 
characteristics of prepared gels could be modified. The ideal formulation 
for the treatment of periodontitis shows good bio-adhesiveness, 
controlled drug release and ease of delivery into the periodontal pocket 
by topical application or by using a syringe. According to the obtained 
results, formulation F11 containing combination of 1 % CP and 5 % CMC 
could offer a compromise of adhesiveness, rheological and controlled 
release behaviors and is a good candidate for periodontal 
administration. Clinical studies of the gel preparation in healthy human 
volunteers should be evaluated in the future. 
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